American Diabetes Association, June 3-7 – Consumer Health News

The American Diabetes Association’s annual meeting was held June 3-7 in New Orleans this year and attracted more than 15,000 attendees from around the world, including clinicians, academics, allied health professionals and others interested in diabetes. The conference highlighted the latest advances in diabetes research and improving patient care, with presentations focusing on treatment recommendations and advances in management technology.

In a study, Elizabeth Lundeen, Ph.D., of the Vision Health Initiative (VHI) at the U.S. Centers for Disease Control and Prevention in Atlanta, and her colleagues found that the decline in visual impairment in older adults aged 18 or over with diabetes leveled off during 2012.

CDC VHI works to improve vision health in the United States through collaborations with state and national partners to strengthen science and develop interventions that promote eye health and prevent vision loss and blindness in high-risk groups. risk. For this study, the authors examined data from 52,000 respondents, ages 18 and older, with diagnosed diabetes, using self-reported data from the US National Health Interview Survey over a period of 20 years ranging from 1999 to 2018. Researchers found that the prevalence of visual impairment among people with diabetes decreased significantly from 1999 to 2012. However, this trend began to change in 2012. From 2012 to 2018, there is had an increase in prevalence in this population.

“Although this latest trend of increasing prevalence of visual impairment from 2012 to 2018 did not reach statistical significance, it could be an early warning that trends in visual impairment among people with diabetes are going to increase. in the wrong direction,” Lundeen said. “These results are noteworthy as they suggest that the decline in visual impairment in adults with diabetes seen in the first decade of the century may have ended around 2012. A number of factors could influence these results, such as changes in blood sugar management in people with diabetes or changes in vision screening or health care utilization in this population.Future research exploring these possible causes could help us better understand these trends and design appropriate interventions.

Press release

In another study, Deborah Ellis, Ph.D., of Wayne State University in Detroit, and her colleagues found that residential racial segregation had independent effects on hemoglobin A1c (HbA1c) in young black people with diabetes. type 1 after controlling for family income and neighborhood adversity. .

The authors assessed the effects of racial residential segregation on the health of young black people with type 1 diabetes. The study examined the effects of living in highly segregated neighborhoods on HbA1c, while controlling for factors such as as age, insulin delivery method, family income and other aspects of neighborhood adversity. The researchers found that higher levels of racial residential segregation were associated with higher HbA1c even after controlling for family income and neighborhood adversity.

“The study demonstrates the influence of social determinants of health on health outcomes in young people of color with type 1 diabetes,” Ellis said. “This shows the importance for healthcare providers to ask questions about the factors that affect young people’s diabetes health and address them beyond day-to-day diabetes management.”

An author disclosed financial ties to Boehringer Ingelheim.

Abstract No. 569-P

ADA: Diabetes may quadruple risk during long period of COVID

WEDNESDAY, June 8, 2022 (HealthDay News) — Diabetes may quadruple the risk of long-lasting COVID symptoms, according to a study presented at the American Diabetes Association’s annual meeting, held June 3-7 at the New Orleans.

Read the full text

ADA: Comparison of insulin delivery systems in type 1 diabetes

WEDNESDAY, June 8, 2022 (HealthDay News) — An open source automated insulin delivery system appears to be safe and effective for use in people with type 1 diabetes, according to a study presented at the annual meeting of the ‘American Diabetes Association, held June 3-7 in New Orleans.

Read the full text

ADA: dulaglutide once a week improves glycemic control in young people with T2DM

TUESDAY, June 7, 2022 (HealthDay News) — For young people with type 2 diabetes, dulaglutide is superior to placebo in reducing average glycated hemoglobin levels, according to a study published online June 4 in the New England Journal of Medicine to coincide with the American Diabetes Association’s annual meeting, held June 3-7 in New Orleans.

Read the full text

ADA: tirzepatide once a week allows lasting weight loss in obesity

TUESDAY, June 7, 2022 (HealthDay News) — For obese people, tirzepatide is associated with sustained weight loss, according to a study published online June 4 in the New England Journal of Medicine to coincide with the American Diabetes Association’s annual meeting, held June 3-7 in New Orleans.

Read the full text

ADA: High BMI in adolescence linked to T1D in young adults

MONDAY, June 6, 2022 (HealthDay News) — High body mass index in adolescence is associated with an increased risk of type 1 diabetes in young adults, according to a study published online June 5 in Diabetology to coincide with the American Diabetes Association’s annual meeting, held June 3-7 in New Orleans.

Read the full text

ADA: tirzepamide improves renal outcomes in T2DM with increased CV risk

MONDAY, June 6, 2022 (HealthDay News) — An exploratory analysis of data from the SURPASS-4 trial showed that adults with type 2 diabetes and increased cardiovascular risk receiving tirzepatide had fewer kidney complications, particularly kidney complications. appearance of macroalbuminuria; these results were presented at the annual meeting of the American Diabetes Association, held June 3-7 in New Orleans.

Read the full text

Comments are closed.